Table_5.xls (9.5 kB)
CMAP values by treatment arm – 6 month values and change from baseline.
dataset
posted on 2010-08-19, 01:36 authored by Kathryn J. Swoboda, Charles B. Scott, Thomas O. Crawford, Louise R. Simard, Sandra P. Reyna, Kristin J. Krosschell, Gyula Acsadi, Bakri Elsheik, Mary K. Schroth, Guy D'Anjou, Bernard LaSalle, Thomas W. Prior, Susan L. Sorenson, Jo Anne Maczulski, Mark B. Bromberg, Gary M. Chan, John T. Kissel1
= placebo group received matched placebo for both medications, L-carnitine and VPA.
2= active treatment group received both L-carnitine and VPA.
*Difference = 0.121. Upper confidence level difference 0.568. Lower confidence level difference −0.328.
**Difference = 0.570. Upper confidence level difference 1.465. Lower confidence level difference −0.326.
